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Computational insight into dynamic properties of 
dipeptidyl peptidase III from Bacteroides 
Thetaiotaomicron and the structural basis for its 
substrate specificity 
 
M. Tomina, and S. Tomića* 
Dipeptidyl peptidase III (DPP III) from the human gut symbiont Bacteroides thetaiotaomicron (Bt) is the 
first identified prokaryotic DPP III orthologue. It has low sequence similarity to the thoroughly studied 
human DPP III, and differently from eukaryotic orthologues it has a cysteine (Cys450) residue in the zinc-
binding motif HEXXGH (HECLGH). Recently determined crystal structure of Bt.DPP III showed that its 
3D structure, similarly to the structure of the human DPP III, consists of two domains with a wide cleft 
inbetween. Although such a striking similarity of the 3D structures of orthologues with low sequence 
similarity is not surprising, it is no guarantee for similarity of their dynamic properties and the catalytic 
performance. Here we report results of the molecular modelling study of Bt.DPP III, wild type and its 
C450S mutant as well as their complexes with characteristic DPP III substrates Arg-Arg-2-naphthylamide 
(RRNA) and Lys-Ala-2-naphtylamide (KANA). During several hundred nanoseconds of all atom MD 
simulations of the wild type protein the long range conformational changes which can be described as 
protein ‘closing’, have been traced.  Similar conformational change we had determined for the human 
orthologue as well. However, the amplitude of the change is lower for Bt.DPP III than for the human DPP 
III. The MD simulations have been performed using ff03, ff12SB and ff14SB force fields wherein the 
results of the last two better fit to the experimental results. The calculated free energies combined with the 
hydrogen bond analysis indicate reasons for higher substrate specificity of Bt.DPP III towards RRNA than 
KANA as well as for decrease of the RRNA hydrolysis rate induced by the Cys450 to Ser mutation. The 
obtained results are in line with the experimental data.  
 
 
1. Introduction 
Peptidases are a type of hydrolases that primarily hydrolyse 
peptide bonds in proteins and peptides to release amino acids or 
shorter peptides. Classification of peptidase into families is based on 
their sequence homology while subdividing of the families into clans 
is based on similarities in three-dimensional structures, and the 
sequences comprising catalytic amino acid residues1.
 Dipeptidyl peptidases III (DPP III) or M49 peptidases 
(according to the MEROPS database, http://merops.sanger.ac.uk/)2 
are zinc-dependent peptidases that cleave dipeptides from the amino-
end of their substrates, peptides consisting of 3 or more amino acid 
residues (preferable 3-8) and have a role in protein catabolism, pain 
modulation, as well as in defense against oxidative stress.1, 3, 4  The 
first 3D structure determined for a DPP III was the crystal structure of 
yeast DPP III (pdb code: 3csk).5 Crystal structures of human DPP III 
followed (pdb codes: 3T6B and 3FVY).6 The 3D structure of DPP III 
from Bacteroides thetaiotaomicron was just recently uploaded to 
PDB. All these structures have the unique protein fold resembling two 
domains separated by a wide cleft. The zinc-binding site is in the 
upper, catalytic domain, next to the cleft, and represents a part of the 
enzyme active site. Both, experiments and calculations revealed that 
the eukaryotic DPP IIIs exhibit long range conformational motion 
which can be described as protein closure/opening (two domains 
approaching each other). During the motion, the conformation of each 
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protein domain remains conserved.6, 7  DPP III from 
Bacteroides thetaiotaomicron (Bt.DPP III) is the first bacterial DPP 
III for which the crystal structure was solved. Bacteroides 
thetaiotaomicron is a Gram-negative anaerobe, a predominant 
member of the normal intestinal microbiota of mammals.8, 9 
 Sequencing of the B. thetaiotaomicron genome revealed 
4779 protein coding genes and a highly adaptable organism able to 
compete with hundreds of the other bacterial species for survival in 
the colon environment.9 Bacteroides thetaiotaomicron is of great 
importance for study of the symbiotic host-bacterial relationship 
within the human intestine.10 However, this bacterium is known also 
as an opportunistic pathogen, resistant to a wide variety of 
antibiotics,11 which is of clinical interest. 
To investigate structural and dynamic properties of the bacterial 
Bt.DPP III and its complexes with characteristic DPP III substrates, 
Arg-Arg-2-naphthylamide (RRNA) and Lys-Ala-2-naphtylamide 
(KANA), we performed a detailed molecular modelling study. 
Docking, accompanied with the long all atom MD simulations 
(conventional and accelerated), was performed in order to determine 
the way of substrates binding into the Bt.DPP III active site as well as 
to learn about the influence of ligand on protein structure and 
dynamics. Convential MD simulations (cMD) powered by the 
accelerated MD12, 13 (aMD) simulation enabled efficient searching of 
the conformational space. Besides just tracing the interconversion 
from the open to the closed protein form we have been interested in 
the mechanism driving this conversion. For this purpose the 
conformational changes determined during simulations of different 
Bt.DPP III variants as well as their complexes with the characteristic 
DPP III ligands, were compared and analysed in the light of changes 
determined for human DPP III.  
The present study is the first computational study of a bacterial 
DPP III. We showed that Bt.DPP III, similarly to the eukaryotic 
DPP IIIs, experiences the long range conformational motion 
(considered as protein closure) which is promoted by binding of 
a substrate into the enzyme active site. However, the extent of 
this motion determined for Bt.DPP III is smaller than for the 
human orthologue. Analysis of the intermolecular hydrogen 
bonds, combined with the MM-PBSA free energy calculations, 
enabled us to rationalize the experimentally determined 
difference in the Bt.DPP III catalysed hydrolysis of the synthetic 
substrates RRNA and KANA as well as to elucidate reasons for 
significant drop of the RRNA hydrolysis induced by the Cys450 
to Ser mutation.14 The simulations were performed using three 
different force fields, ff03, ff12SB and ff14SB. Comparison with 
the available experimental data suggests that ff12SB and ff14SB 
are more suitable for study of the zinc-dependent peptidases than 
the ff03 force field.   
 
2. Methods 
2.1. System preparation 
The experimentally determined structure of the ligand free Bt.DPP III 
fourfold mutant was used as the initial structure for our molecular 
modeling study. In the mutant Cys residues (143, 174, 419 and 435) 
are replaced by Ser, and Met residues (83, 103, 122, 165, 207, 513, 
517, 534, 556 and 660) by selenomethionine (Se-Met).  For the 
purpose of molecular modelling of the wild type enzyme Ser and Se-
Met were reverted back to Cys and Met, respectively. The amino acids 
residues missing at the N terminal of the experimentally determined 
structure, Met1 – Lys23, were partially (Thr16 – Lys23) reconstructed 
using the program Modeller 9.14.15 The first 15 amino acids were 
omitted because there are strong evidences that they constitute a 
signalling sequence, as predicted by the SignalP16 server (Figure S1). 
Both Se-Met to Met and Cys to Ser transformations were performed 
by editing the pdb structure and rebuilding the residues with tleap, a 
basic preparation program for Amber simulations available within the 
AMBER14 package (http://ambermd.org).17, 18 In the model all Arg 
and Lys residues are positively charged (+1e) while Glu and Asp 
residues are negatively charged (-1e), as expected at the physiological 
(experimental) conditions. The protonation of histidines was checked 
according to their ability to form hydrogen bonds with neighbouring 
amino acid residues or to coordinate the metal ion. The protein 
parametrization was performed within the three AMBER force fields: 
ff03,19 ff12SB20 and ff14SB,21 while the substrate was parameterized 
within the generalized amber force field (gaff)22 and the missing 
parameters were derived using Antechamber23 module within the 
Amber14 suit of programs. For the zinc cation, Zn2+, parameters 
derived in previous work were used.24  
The proteins and protein-substrate complexes, were placed into 
the truncated octahedron box filled with TIP3P water 
molecules,25 and Na+ ions26 were added in order to neutralize the 
systems. 
 
2. 2 Simulations. 
Conventional MD (cMD) simulations. 
 System preparation, geometry optimization and equilibration 
were as followed. Prior to molecular dynamics simulations, the 
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protein geometry was optimized in three cycles with different 
constraints. In the first cycle (1500 steps), only water molecules 
were relaxed, while the protein and zinc atoms were restrained 
by the harmonic potential with a force constant of 32 kcalmol-
1Å-1. In the second (2500 steps) cycle, the same force was applied 
to the zinc atom while the backbone atoms were relaxed. In the 
third cycle (1500 steps), all atoms were free to move. During the 
first period of equilibration (50 ps of gentle heating from 0 to 
300K), the NVT ensemble was used, while all of the following 
simulations were performed at constant temperature and pressure 
(300K and 1 atm, the NpT ensemble). 
 In order to reduce any bias that the force field could have on 
the simulation results, we performed 200 ns of NpT MD 
simulations (300 K, 1 atm, time step 2 fs) using ff03, ff12SB and 
f14SB force fields. The temperature was held constant using 
Langevin dynamics with a collision frequency of 1 ps−1. Pressure 
was regulated by a Berendsen barostat. Bonds involving 
hydrogen atoms were constrained using the SHAKE algorithm.  
 Accelerated MD (aMD) simulations. The solvated systems 
(ligand-free DPP III and DPP III-RRNA complex) obtained after 50 
ps of heating from 0 to 300K were used as the starting structures for 
dual boost accelerated MD simulations (aMD).  Differently from 
some alternative methods, the aMD simulations do not require prior 
knowledge of the potential energy landscape, i.e. a reaction coordinate 
does not need to be defined prior to running simulations. In the dual 
boosting approach, one boost potential is applied to the torsional terms 
and the other, different, boost potential to the total potential. The latter 
diminishes the moment of inertia of bulky water and thus facilitates 
diffusion of the explicit solvent molecules around the biomolecule. 
The average total potential energy, 𝐸𝑝𝑜𝑡̅̅ ̅̅ ̅̅ , and the average torsional 
potential energy, 𝐸𝑑𝑖ℎ̅̅ ̅̅ ̅̅ , for the simulated systems, were obtained from 
the 200-ns-long cMD simulation of the open DPP III structure (see 
Table 1). 𝐸𝑟 and 𝐸𝑎 are the parameters (energy per residue and atom, 
respectively) used to calculate the potential energy boost ET(r) and the 
torsional potential energy boost Et(r), respectively, as well as the 
parameters controlling roughness of the boost potentials, αT and αt, 
respectively.12, 27 The simulations (NpT, time step 2 fs combined with 
the SHAKE algorithm, Langevin thermostat, Berendsen barostat) 
were conducted with the AMBER12 package (GPU version)28 using 
the ff14SB force field. An overview of all simulations performed 
within this work is given in Table S1. 
Table 1. Average energy values from a 200 ns long MD simulation using 
ff14SB and the parameters required for aMD simulations. All values are 
given in kcal mol-1. 
𝐸𝑝𝑜𝑡̅̅ ̅̅ ̅̅
a -263551.9 
𝐸𝑑𝑖ℎ̅̅ ̅̅ ̅̅
a 8463.7 
𝐸𝑟 
b  1.0 
𝐸𝑎
b  0.1 
𝐸𝑡ℎ𝑟𝑒𝑠ℎ𝑃 -254890 
𝛼𝑃 8662 
𝐸𝑡ℎ𝑟𝑒𝑠ℎ𝐷 9123 
𝛼𝐷 132 
aAverage potential and dihedral energies. bEr and Ea are the energy per residue 
and atom, respectively, used to calculate threshold energies and α .27  
Docking. Recent simulations of the human DPP III – RRNA 
complex had shown that RRNA forms strong and persistent 
interactions with the binding site when the enzyme is in the more 
compact form.7 In order to let the substrate achieve the optimal 
conformation, the partially closed structure obtained from MD 
simulations of the ligand free protein was used. Docking was 
performed manually using the structure of the h.DPP III – RRNA 
complex as a template29. Initial Bt.DPP III – RRNA and Bt.DPP 
III – KANA complexes were geometry optimized, equilibrated 
and simulated for 200 ns. The Bt.DPP III – KANA complex was 
prepared from the structure of the Bt.DPP III – RRNA complex 
obtained after 100 ns. After minimization and equilibration the 
Bt.DPP III – KANA complex was simulated for 100 ns. The 
simulation procedure was same as for the ligand free enzyme. 
Classical MD using ff12SB and ff14SB, as well as accelerated 
MD using ff14SB were chosen for fine tuning of the initial, 
manually performed docking and to trace the influence of ligand 
on protein dynamics.  
MM-PBSA calculations. The substrates binding free energies 
were obtained using the MM-PBSA approach as implemented in 
AMBER12 program.30 MM-PBSA calculations were performed 
for the complexes with the wild type enzyme, DPP III – RRNA 
and DPP III – KANA, as well as for the complex with its mutant, 
C450S DPP III, C450S – RRNA. For each complex the binding 
free energies have been calculated on 5 ns long intervals sampled 
throughout the trajectory. The calculations were performed using 
a salt concentration of 0.15M. Additionally the MM-GBSA 
calculations, utilizing GB model of Onufriev et al.31 have been 
performed as well. 
2.2. Data analysis 
In order to analyze and to characterize the conformational space 
that Bt.DPP III structures (experimental and those generated 
during MD simulations) span, as well as to determine the most 
relevant motions associated with protein closure, several types of 
data analysis were performed. All calculations were performed 
with CPPTRAJ module of the AmberTools program package.32 
Geometric parameters. In order to quantify differences among 
the Bt.DPP III forms, either generated computationally or 
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obtained by X-ray diffraction, several geometric parameters, 
given in Table 2, were analyzed. 
 In general, the radius of gyration (Rg) is a good measure of 
the long ranged conformational changes. However, in the case of 
Bt.DPP III, which has a significant number of unstructured 
regions (loops) it is not a perfect measure of protein closure. 
Therefore we used 3 additional geometrical parameters, namely 
d1 – d3, as given in Figure 1. Equivalent distances were traced 
during MD simulations of human DPP III.7 
Hydrogen bonds. Intermolecular hydrogen bond analysis was 
performed on same sections of the trajectories as MM-PBSA 
calculations in order to closely examine the ligand-protein 
interactions. The cutoff distance and angle for hydrogen bonds 
was set on a default values of 3.0 Å and 135°, respectively. These 
relatively tight criteria ensured that only the most relevant 
interactions were taken into account. 
Principal component analysis. As the main criteria for 
selecting the appropriate computational procedure we considered 
its ability to adequately sample the protein conformational space. 
In order to quantify this, two principal components were 
calculated using the trajectories sampled during entire set of 
simulations (Table S1), in a way described by Roe et al.33 and all 
the data was projected on two PCs. 
3. Results and discussion 
3.1. Protein flexibility 
The wide interdomain cleft, for example distance between the Cα 
atoms of D14 and N15 residues at the outer edge of the cleft and 
belonging to the upper and lower domain, respectively, is 42 Å, 
large enzyme promiscuity, and the presence of two of the five 
highly conserved regions in the lower protein domain, suggest 
that the Bt.DPP III, similarly to human and yeast orthologues 
could experience long-ranged inter-domain motion. In order to 
thoroughly investigate the long range conformational changes of 
Bt.DPP III, and to find out how substrate influences these 
changes, we performed a series of cMD and aMD simulations of 
ligand free Bt.DPP III and its complexes with RRNA and 
KANA. The final structures obtained by simulations of the 
ligand free wild type enzyme are shown in Figure 1 and 
geometrical parameters determined for these structures are given 
in Tables 2 and S2. An increase in protein globularity traced 
during MD simulations, is accompanied by Rg decrease. The Rg 
values calculated for the initial all-atom crystallographic 
structure, x-ray, and the closed enzyme structure obtained after 
200 ns of MD simulations performed using different force fields 
(ff03, ff12SB and ff14SB force fields) are given in Tables 2 and 
S2. The highest and the lowest Rg values are associated with the 
x-ray structures of Bt.DPP III, oXR, and cWT, respectively 
(Table 2). However, distances between Cα atoms of D193-K468, 
D208-K468 and A394-K468, d1, d2 and d3, respectively are more 
appropriate than Rg to describe the mutual orientation of 
domains, and therefore represent good parameters for the 
structures differentiation, see Table 2 and Figure 1. D193, D208 
and A394 belong to sheet 1 and helices 9 and 16 from the lower 
domain while K468 belongs to the helix 20 from the upper 
domain (Fig. 1). 
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Figure 1. Cartoon representations of four different conformations of Bt.DPP III: open crystal structure, oXR (center), closed structure obtained after 200 ns of 
MD simulations using ff03 (top left), ff12SB (top right), ff14SB (bottom left) and ff14SB with accelerated MD (bottom right). Residues D193, D209, A394 
and K468 are shown in stick representation, the zinc ion as a gray sphere, and d1 (D193-K468), d2 (D209-K468) and d3 (A394-K468) Cα distances are 
indicated by the black dashed lines. 
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Variability of the conformational space sampled during MD 
simulations was assessed by similarity of the structures from the 
most distant conformational regions with the 
crystallographically determined structures of the ‘open’ and 
‘closed’ of Bt.DPP III forms (oXR and cWT, respectively). The 
shape of the protein domains in the crystallographically 
determined structures is conserved (RMSD between domains in 
the oXR and cWT 0.435 Å and 0.259 Å for the upper and lower 
domain, respectively). During MD simulations domains also 
have not changed their conformation significantly so the RMSD 
calculated for the entire structure mostly represents the 
difference in mutual orientation of these domains (Figures S2 – 
S5). However, the other four geometric parameters, Rg, and the 
Cα distances D193-K468 (d1), D208-K468 (d2) and A394-K468 
(d3) (Fig. 1), are more appropriate to quantify differences among 
the sampled conformations. While the closed structure obtained 
by aMD simulations of the ligand free protein has d3 (A394-K46) 
significantly shorter than the crystallographically determined 
structures oXR and cWT, see Table 2, d3 of the structures 
obtained by simulation of the complexes (WT-RRNA and WT-
KANA) is similar to that of the cWT structure. 
Table 2. Values of geometric parameters used to describe the degree and type 
of Bt.DPP III closure determined in the most distinct enzyme structures. The 
oXR and cWT structures are obtained by X-ray diffraction, while structures 
in the last three columns, WTMD, WT-RRNA and WT-KANA are obtained by 
molecular modelling. The radius of gyration (Rg) was calculated for the 
protein backbone atoms. The distances d1 – d3 were calculated for Cα atoms. 
geometric 
parameters 
oXR cWT 
 
WTMD
a 
WT-
RRNAb 
WT-
KANAb 
 
Rg / Å 26.7 24.8 25.6 25.3 25.2 
d1(D193-
K468) / Å 
41.2 24.1 33.8 24.0 25.2 
d2(D208- 
K468) / Å 
32.9 20.6 25.2 21.8 20.7 
d3(A394- 
K468) / Å 
26.0 22.6 7.5 19.9 19.4 
a aMD-ff14SB, b cMD-ff14SB + aMD-ff12SB 
It should be noted that the experimentally determined so called 
‘open’ structure is for the fourfold Cys to Ser mutant while the 
simulations were performed for the wild type enzyme. In order 
to more efficiently explore the conformational space, besides 
conventional, the accelerated MD simulations using the ff14SB 
force field were performed as well. The added dual-boost 
potential boosted the protein closure (noticed as the sudden 
decrease of the radius of gyration, as well as of the d3 value, 
Figure 2) and aMD simulations sampled much larger region of 
the enzyme conformational space (see Fig. 3) than conventional, 
cMD, simulations. However, the modes of protein closure 
obtained by aMD and cMD simulations differ (Figure S6). The 
mode of closure determined by aMD simulations is in agreement 
with our earlier MD simulations performed for the human DPP 
III. The mutual orientation of the domains in the WTMD and oXR 
structures slightly differs.  In the WTMD structure domains are 
facing each other while in oXT they shifted are in opposite 
directions in the plain orthogonal to the direction of closure. 7, 27  
  
  
 
Figure 2. The protein radius of gyration and the selected Cα atom distance 
profiles obtained from 200 ns long MD simulations.  
The principal component analysis supports the conclusions 
based on the comparison of the geometrical parameters (Rg, d1, 
d2 and d3). As shown in Figure 3, classical MD simulations using 
either, ff12SB or ff14SB force field, as well as the accelerated 
MD with ff14SB force field, explored larger part of 
conformational space than cMD-ff03 simulations. The 
conformation region obtained by the latter is limited to the space 
of the open and semi-closed conformations. Based on these 
results, cMD-ff12SB and aMD-ff14SB simulations were chosen 
for the substrate docking.  
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Figure 3. Sampling of the conformational space (defined by the first two 
principal components) by MD simulations, cMD-ff12SB (upper left), ff03 
(upper right), ff14SB (lower left) and aMD-ff14SB (lower right). Position of 
the experimentally determined structures oXR and cWT is represented by red 
square and blue hexagon, respectively. 
The principal component analysis was performed on the protein 
backbone atom, omitting the first 10 amino acid residues of the 
N-terminus, for the set of trajectories sampled during either set 
of cMD or aMD simulations accomplished with different force 
fields. The first two principal components describe 
approximately 73% of total variance, with PC1 accounting for 
ca. 43% and PC2 for ca. 30% of variability The concentrated 
motions described by these principal components correspond to 
the protein domains’ movement, as illustrated in Figure 4. The 
modes of motion are similar to those described for human DPP 
III.7 
  
Figure 4. Concentrated protein motions corresponding to the first (left) 
and the second (right) principal component. 
Normal mode analysis was performed using the Delarue group 
server,34 and the obtained modes agree well with the principal 
components calculated from our trajectories (results not given). 
RMSF values calculated for the individual residues of APO form 
revealed that the residues from the upper (Leu328 – Lys365; 
Ser455 – Ala477; Val521 – Ala619) and lower (Val175 – 
Val235) domain which constitute the outer rim of the 
interdomain cleft correspond to the most flexible regions 
(Figures S7 – S10) indicating that the long range protein closure 
is indeed the dominant structural change noticed during MD 
simulations. Similar results have been previously reported for the 
human orthologue as well.7  
3.2. Zinc ion coordination 
The crystal structure of the ligand-free Bt.DPP III revealed the 
six-coordinated zinc ion coordinated by two histidines (His463 
and His458), two glutamates (Glu449 and Glu476) and two 
water molecules (Figure 5) wherein both glutamates coordinate 
Zn2+ monodentately. These His and Glu residues are a part of 
two conserved regions in the DPP III family, HEXXGH(HG) and 
EECR(K)A.35  
  
 
 
During MD simulations His463, His458, Glu449 and Glu476 
remained in the Zn2+ coordination sphere, even more, differently 
from the initial structure, glutamates occasionally coordinated 
the metal ion bidentately. However, Glu449 and Glu476 never 
coordinate Zn2+ at the same time, see for example Figure 6). Such 
behavior of glutamates aids to the zinc ion stabilization during 
the water exchange. During aMD-ff14SB simulations, exchange 
of the carbonyl oxygens in the zinc coordination sphere was 
noticed only in the case of Glu476 (Figures S11 and S12).  
 
 
Figure 6. Distance between Zn2+ and the carboxyl oxygens of coordinating 
Glu449 (left) and Glu476 (right) residues during aMD-ff14SB simulation. 
During the first 100 ns of simulations the water molecules 
exchanged fairly often within the Zn2+ coordination sphere 
(Figure 7) but by the protein closure exchange of water 
molecules from the coordination sphere with those in the bulk 
becomes less frequent, and the two molecules trapped in the Zn2+ 
coordination sphere at 150th ns remain there until the end of 
simulation. The number of water molecules in the Bt.DPP III 
active site and close to it significantly decreased during the last 
50 ns of MD simulations. 
 
a) b) 
c) 
Figure 5. The Zn2+ coordination 
sphere in the a) initial structure 
used for cMD-ff12SB simulation; 
b) at the end of the simulation; c) in 
the snapshot at 157th ns 
representing the structure close to 
the moment of water exchange. 
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Figure 7. Water molecules in the Bt.DPP III active site, a) “Resistance time” 
for the water molecules coordinating Zn2+ in the unligated enzyme during 
200 ns of cMD-ff12SB simulation. b) Number of water molecules occupying 
the 10 Å sphere around the zinc ion over the course of the 200 ns of cMD-
ff12SB simulation 
3.3. The role of Ser340 and Tyr386 
The computational studies revealed important role of Ser340 for 
the protein closure. Namely the Ser340 - Asp446 hydrogen bond 
formed at the early stage of MD simulations (5th – 10th ns) 
facilitates the interdomain motion through the Ser363-Asp446-
Arg333-Glu432 chain of interactions. Similar role was 
determined for its analogue Asp372 in human DPP III.36 
Tyr286 is 100% conserved within the M49 family and is 
presumed to be a part of the S1 active subsite.37 Both 
experimental38 and computational7 studies have shown its 
functional role in the human orthologue (Tyr318). The 
magnitude of its translocation during MS simulations of the 
ligand free Bt.DPP III is fairly large, with distance from its Cα 
atom to Zn2+ decreasing from 29.7 Å in the open crystal structure 
to 20.6 Å after at 200th ns of MD simulations. In the 
experimentally determined ‘closed’ structure of the Bt.DPP III 
this distance is 22.2 Å. During the MD simulations resulting with 
the protein closure Tyr286 forms hydrogen bonds with Lys468, 
Gly461 and, most notably, Ser472 which is thought to be a part 
of the S2 subsite.37  
3.4. MD simulations of the DPP III – RRNA complex  
The structure of the human DPP III – Arg2-2NA (RRNA) 
complex from our previous computational works7, 36 was used as 
a template to construct the Bt.DPP III – substrate complexes. The 
substrates were docked into the semi-closed Bt.DPP III 
conformation determined during MD simulations of the ligand 
free enzyme. 
The initial binding mode of the preferred substrate, RRNA 
closely resembles the binding mode of the peptide tynorphin in 
the crystal structure of human DPP III-tynorphin complex (pdb 
code: 3T6B). In this structure tynorphin has the form of a β-
strand and binds to the five-stranded β-core of the lower domain 
in an anti-parallel fashion.6 Our MD simulations suggest that 
RRNA binds to Bt.DPP III in the same manner, antiparallel to 
the Gly383 – Leu386 strand of the β-sheet 5. This is in agreement 
with RRNA binding to the human ortholog.7, 27 
In order to study the effect of the ligand binding on the rate, 
degree and type of the protein closure, we simulated the Bt.DPP 
III – RRNA complex for 200 ns using cMD-ff12SB and aMD-
ff14SB approaches. By comparing the radii of gyration and the 
geometrical parameters d1 – d3 (Figure 1), we can conclude that 
the ligand boosts the protein closure (Figures 2 and 8). A sudden 
drop in the radius of gyration during the first 50 ns of MD 
simulations is clearly visible in the case of the complex, while 
the unliganded enzyme needed around 80 ns to achieve the 
similar Rg value. The distance between the Asp193 and Lys468 
Cα atoms oscillates around 28 Å over the first 130 ns of the 
simulation in the case of unliganded enzyme, whereas the same 
distance dropped to 25 Å within the first 80 ns of MD simulations 
of the complex. 
  
  
 
Figure 8. The protein radius of gyration and the selected Cα atom distance 
profiles determined for the Bt.DPP III – RRNA complex during 200 ns long 
MD simulations. 
When considering water population in the active site (Figures 
S13 and S14) we can notice several fast water exchanges in the 
zinc coordination sphere in the period of 40th - 110th ns of the 
cMD-ff12SB simulation time. This corresponds to the substrate 
reorientation within the enzyme active site. During the second 
half of the simulation time fluctuations of RRNA molecule 
decreased (RMSF value decreased from 1.97 Å during the first 
100 ns of the simulation to 1.28 Å during the last 100 ns) and it 
sterically protects the Zn2+ ion from bulky water molecules. The 
average number of water molecules within 10 Å of the zinc ion 
determined for the last 50 ns of simulations was only about 47 
(+4) wherein the number of water molecules coordinating Zn2+ 
was two during most of the simulation time. Similar trend of 
substrate stabilization has been observed during the aMD-
ff14SB simulations as well (RMSF decreased from 2.21 Å to 
1.54) Å. However, differently from the cMD-ff12SB simulation, 
Zn2+ was coordinated by only one water molecule during aMD-
ff14SB simulation (Figure S15) and the Zn2+ coordination 
number varied between 6 and 7 depending on the Glu476 
orientation and its participation in the metal ion coordination as 
a mono- or bidentate ligand (Figure S16). During entire cMD-
ff12SB simulation of the Bt.DPP III – RRNA complex Glu476 
coordinated the metal ion monodentately with exchange of the 
carboxyl oxygens in the zinc coordination sphere (Figure S17). 
All these findings are in accord with previously determined high 
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plasticity of the zinc ion coordination. Glu449 coordinates Zn2+ 
exclusively in a monodentate manner through O2 in both types 
of simulations (Figures S18 and S19). 
The principal component analysis (Figure 9) clearly indicates 
that the presence of substrate influences the Bt.DPP III closure 
in the direction of cWT form. Differently from the aMD-ff14SB 
simulation of the ligand free enzyme, the protein conformational 
change observed during aMD-ff14SB simulation of the Bt.DPP 
III – RRNA complex corresponds to the protein closure to the 
experimentally determined cWT form, i.e. form in which 
domains are with respect to the initial, open structure shifted in 
opposite directions in the plain orthogonal to the direction of 
closure (Figure S20). This finding is in agreement with our 
previous results on the human orthologue that ligand binding into 
the inter-domain cleft enhances the protein closure and domains 
shifting. 
  
Figure 9. The Bt.DPP III conformational space, defined by the first two 
principal components, sampled during the cMD-ff12SB (left) and aMD-
ff14SB (right) simulations of Bt.DPP III – RRNA complex. Position of the 
experimentally determined structures oXR and cWT is represented by red 
square and blue hexagon, respectively. 
During the simulations RRNA accommodated into the active site 
in the similar manner as tynorphin in the human orthologue, with 
the naphthalene ring located in a hydrophobic pocket (Figure 
10).7 The most notable difference between the binding modes 
obtained by cMD-ff12SB and aMD-ff14SB simulation 
procedures is the position of the substrate aromatic ring. During 
the aMD simulation, it enters deeper into the hydrophobic pocket 
than during cMD simulation. In both cases, RRNA is stabilized 
by hydrogen bonds with Glu320, Gly383 and Glu476. The final 
structure of the complex obtained by cMD-ff12SB simulation 
contains an additional hydrogen bond between RRNA and 
Asn385, while in the structure obtained by aMD-ff14SB 
simulation RRNA is H-bonded to Glu531 (Figure 10). 
  
  
Figure 10. Electrostatic potential surface of the active site calculated by 
APBS plugin for PyMOL39 and intermolecular Bt.DPP III - RRNA hydrogen 
bonds (blue) in the lowest energy conformations obtained by cMD-ff12SB  
(left) and aMD-ff14SB simulations (right). 
In order to determine the most stable complex conformation, the 
lowest-energy conformation obtained by the aMD-ff14SB 
simulation was taken as a starting point for additional 100 ns of 
cMD-ff12SB simulation. As a result, a conformation given in 
Figure 11 was obtained. In addition to the 4 hydrogen bonds that 
RRNA formed in previously acquired structures (with Glu320, 
Gly383, Glu476 and Glu531), in this complex RRNA is further 
stabilized by hydrogen bonds with His119, Thr306 and Glu307 
(Table 4 and Figures S21 and S22). Consequently, the binding 
free energy decreased.  
Surface-accessible solvent 
area (SASA) was 
calculated using 
NACCESS.40, 41 Large 
decrease of per-residue all-
atom SASA (>45 Å2) in 
the final Bt.DPP III – 
RRNA complex in 
comparison to the 
unliganded enzyme 
indicates that RRNA 
hinders the solvent access 
to the cleft-lining amino 
acid residues, as well as to 
the “hinges” connecting 
the two domains (Figure 
S23 and S24). Similar 
behaviour has been reported for human DPP III complexes with 
RRNA.7  
Figure 11. Hydrogen bond network in 
the Bt.DPPIII - RRNA obtained after 
100 ns of aMD-ff14SB followed by 100 
ns of cMD-ff12SB simulation. 
Journal Name ARTICLE 
This journal is © The Royal Society of Chemistry 2012 J. Name., 2012, 00, 1-3 | 10  
3.4. MD simulations of the DPP III – KANA complex 
The experimental data available for the wide variety of 
dipeptidyl-2-naphtylamides shows that Bt.DPP III most 
efficiently catalyzes hydrolysis of RRNA while the hydrolysis 
rate for Lys-Ala-2NA (KANA) is an order of magnitude lower.14 
In order to rationalize this data, KANA was docked into a semi-
closed enzyme structure obtained after 100 ns of simulations of 
the Bt.DPP III – RRNA complex. The system was heated and 
minimized as described in system preparation and simulated for 
100 ns using classical MD with ff12SB and accelerated MD with 
ff14SB force field. After these simulations, the same procedure 
as for the Bt.DPP III – RRNA complex was used. The binding 
free energies obtained by MM-PBSA and given in Tables 3 and 
S3 are in line with the experimental data reported by Vukelić et 
al.14 
Table 3. The binding free energies for the Bt.DPP III-RRNA and Bt.DPP III-
KANA complexes obtained by MM-PBSA calculations. 
Complex Method ΔEPB/kcalmol-1 
DPP III - RRNA cMD-ff12SB -49.76 
DPP III - KANA cMD-ff12SB -41.41 
DPP III - RRNA aMD-ff14SB -57.83 
DPP III - KANA aMD-ff14SB -35.33 
DPP III - RRNA 
aMD-ff14SB + 
cMD-ff12SB 
-67.27 
DPP III - KANA 
aMD-ff14SB + 
cMD-ff12SB 
-47.68 
 The difference in the binding affinities of RRNA and KANA 
can partly be explained by the hydrogen bond analysis, see Table 
4. Apparently, the population of the intermolecular substrate-
protein hydrogen bonds is significantly higher in the Bt.DPP III 
– RRNA complex than in the Bt.DPP III – KANA complex. For 
example the substrate stabilization by the hydrogen bonds with 
Gly383 and Glu320, commonly present in the complex with 
RRNA, was not observed in the Bt.DPP III – KANA complex. 
According to the structural differences between RRNA and 
KANA such result was expected. 
Table 4. Hydrogen bonds population (%). The analysis was performed for the 
lowest-energy 5 ns long fragments of the 200 ns long trajectories used to 
calculate the binding energies. Only the hydrogen bonds occurring in >30% 
of the sampled structures are given. 
Acceptor RRNAa RRNAb KANAa KANAb 
Glu307 (I) 31.08 43.88 47.48 - 
Glu307 (II) - 40.84 - - 
Glu320 (I) 70.88 59.44 - - 
Glu320 (II) - 32.40 - - 
Asp375 - - 38.88 - 
Gly383 71.84 - - - 
Glu476 (I) 98.72 35.08 66.76 97.56 
Glu476 (II) 33.36 34.64 55.84 75.56 
Glu476 (III) - 33.24 31.28 - 
Glu531 - 62.72 - 54.40 
Extracted from the trajectory obtained during a200 ns of cMD-ff12SB simulation 
and b100 ns of cMD-ff12SB simulation following 200 ns of aMD-ff14SB 
simulation. 
3.5. MD simulations of the C450S DPP III – RRNA complex 
The earlier performed kinetic measurements clearly indicate that 
Cys450 to Ser mutation significantly reduces catalytic 
performances of Bt.DPP III. For example, in comparison with 
the wild type enzyme C450S mutant has 1.4 times higher Km and 
an order of magnitude lower kcat/Km (µM-1·s-1) for the RRNA 
hydrolyis.14 In order to rationalize this data we performed MD 
simulations of the C450S DPP III – RRNA complex using the 
same starting structure as in the wt-Bt.DPP III – RRNA 
simulations wherein the mutations were performed using the 
AMBER module tleap. The binding free energies calculated 
from the obtained trajectories are in qualitative agreement with 
the experimental data (Table 5). Besides, the hydrogen bond 
analysis also supports the results of kinetic measurements (see 
Table 6). 
Table 5. The binding free energies for wild-type Bt.DPP III and C450S 
Bt.DPP III-RRNA complexes obtained by MM- PBSA calculations. 
Complex Method ΔEPB/kcalmol-1 
wt-DPP III cMD-ff12SB -49.76 
C450S DPP III cMD-ff12SB -44.24 
wt-DPP III aMD-ff14SB -57.83 
C450S DPP III aMD-ff14SB -34.27 
The substrate stabilization by Glu476 is similar in both 
complexes, but Glu307, Glu320 and Gly383 stabilize RRNA 
stronger in the complex with the wild type enzyme than in the 
complex with the mutant. On the other hand RRNA stabilization 
by Glu449 is tighter in the C450S – RRNA than in the wt-Bt.DPP 
III – RRNA complex (Table 6). In both complexes the Glu449 
carboxyl oxygen participates in Zn2+ coordination.  
Table 6. Hydrogen bond analysis on lowest-energy 5ns fragments of used to 
calculate the binding energies 
Acceptor 
% of frames  
WT - RRNA 
% of frames  
C450S - RRNA 
Glu476 (I) 98.72 99.00 
Gly383 71.84 14.44 
Glu320 70.88 - 
Glu476 (II) 33.36 21.60 
Glu307 31.08 - 
Glu449 - 77.84 
 
 
Conclusions 
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In this work, we performed a detailed MD study (cMD and aMD) 
of bacterial, Bacteroides thetaiotaomicron, DPP III, a two-
domain metallopeptidase, in order to study its structural and 
dynamical properties as well as the influence of Cys to Ser 
mutation and ligand binding to these properties.  
 In agreement with the experimental evidence (i.e. X-ray 
structures of the open and closed Bt.DPP III, oXR and cWT, 
respectively), MD simulations revealed that Bt.DPP III can 
transform from the extended structure determined by X-ray 
diffraction, oXR, to a more compact form. However, this 
transformation is not unambiguous; namely there are two distinct 
compact structures, cWT and WTMD, that Bt.DPP III could adopt 
as well as a series of intermediate, so called semi-closed 
structures. The common feature of all these conformations is the 
conserved structure of each protein domain, i.e. the long range 
conformational changes of Bt.DPP III can be described as inter-
domain movements. The main difference between the two 
compact structures is in mutual orientation of its domains. While 
in the WTMD DPP III structure the protein domains are ‘facing’ 
each other similarly as in the open structure, in the cWT structure 
they are shifted in opposite direction in the plain orthogonal to 
the direction of closure (Figure S20). 
 Similar dynamical behavior was earlier found in human DPP 
III.27 However, the amplitude of the interdomain separation is 
significantly larger in human DPP III than in DPP III from 
Bacteroides t. Apparently, the binding site plasticity is higher in 
human DPP III than in bacterial, Bt.DPP III resulting with higher 
substrate promiscuity of the previous. 
 Earlier studies revealed that the closing of human DPP III is 
an entropy-driven process with the major contribution being the 
release of ordered water molecules from the cleft.6, 7, 27 Similarly 
during the simulations presented in this work release of water 
molecules from the inter-domain cleft of Bt.DPP III was noticed. 
Further on the MD simulations presented in this work indicated 
that, like in the case of human orthologue, substrate binding into 
the enzyme active site dictates the protein closure and shifts the 
equilibrium in the direction of the active, cWT, form. 
 Finally, the MD simulations combined with the binding free 
energy calculations and the hydrogen bond analysis revealed that 
affinity of KANA binding into the Bt.DPP III active site is 
significantly lower than that of RRNA. Further on, stabilization 
of the preferred RRNA substrate in the Bt.DPP III active site by 
hydrogen bonds is disturbed by the Cys450 to Ser mutation. In 
conclusion, the present study corroborates the experimental 
findings14 that Bt.DPP III much more efficiently hydrolyzes 
RRNA than KANA, as well as the results of the kinetic 
measurements that revealed significant drop of the RRNA 
hydrolysis by the Cys450 to Ser mutation. 
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